MediLexicon Logo
MediLexicon Logo
Abbreviations        Abbrev Definitions        Dictionary        ICD Codes        Equipment        Hospitals        Drugs        More..

Teczem (enalapril maleate/diltiazem malate)

Company: Hoechst Marion Roussel
Approval Status: Approved October 1996
Treatment for: hypertension
Areas: Cardiovascular / Cardiology; Diabetes / Endocrinology

| General Information | Mechanism of Action |

General Information

Teczem has been approved for the treatment of hypertension. Teczem combines two compounds in a single tablet. Vasotec, manufactured by Merck, is the brand name for enalapril. Cardizem, manufactured by Hoechst Marion Roussel, is the brand name for diltiazem. Indicated for the initial treatment of high blood pressure, Teczem will be manufactured by Merck and marketed by Hoechst Marion Roussel.

Mechanism of Action

Teczem is the first combination product of an ACE inhibitor and a non-dihydropyridine calcium channel blocker. Non-dihydropyridine calcium channel blockers are distinguished by their heart-rate lowering action in the treatment of hypertension.


< back to top

Teczem Drug Information

The Teczem drug information shown above is licensed from Thomson CenterWatch. The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers.

MediLexicon International Ltd Logo

Privacy Policy   |    Disclaimer   |    Contact / Feedback

MediLexicon International Ltd
Bexhill-on-Sea, UK
MediLexicon International Ltd © 2004-2016 All rights reserved.